Perchlorate

Perchlorate

SCHEMBL4878048

O=[N+]([O-])c1cccc(/C=C/c2ccc3ccccc3[n+]2-c2ccccc2)c1O.[O-][Cl+3]([O-])([O-])[O-]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP2C9 P11712 2/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSP90AA1 P07900 1/20 0.43
APAF1 O14727 1/20 0.42
ATM Q13315 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
KMT2A Q03164 7/20 0.40
MEN1 O00255 6/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MAPT P10636 4/20 0.40
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perchlorate SCHEMBL4887190 0.80 ECE2 (0.43) ALDH1A1HSP90AA1KMT2AMEN1NPC1
Perchlorate SCHEMBL4887197 0.80 ECE2 (0.43) ALDH1A1HSP90AA1KMT2AMEN1NPC1
Perchlorate SCHEMBL4882186 0.78 ERN1 (0.38) ERN1ALDH1A1CYP2C9TP53CYP1A2
SCHEMBL5604856 0.71 ERN1 (0.63) ERN1ALDH1A1CYP2C9APAF1ATM
SCHEMBL5604854 0.71 ERN1 (0.63) ERN1ALDH1A1CYP2C9APAF1ATM
SCHEMBL4887194 0.71 KMT2A (0.44) ALDH1A1HSP90AA1KMT2AMEN1NPC1
Perchlorate SCHEMBL4887854 0.70 MAPT (0.45) ERN1ALDH1A1CYP2C9TP53CYP1A2
Perchlorate SCHEMBL5267081 0.70 MAPT (0.45) ERN1ALDH1A1CYP2C9TP53CYP1A2
Perchlorate SCHEMBL5270331 0.70 ALDH1A1 (0.53) ERN1ALDH1A1CYP2C9TP53CYP1A2
SCHEMBL6785545 0.69 MAPT (0.73) ERN1ALDH1A1CYP2C9HSP90AA1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080281105-A1 Novel Quinolinium Salts and Derivatives IMMUSOL INCORPORATED (US) 2008-11-13 US disclosed
EP-1841428-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES Immusol Incorporated (US) 2007-10-10 EP disclosed
WO-2006078754-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES IMMUSOL INCORPORATED (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281105-A1 Novel Quinolinium Salts and Derivatives NQO2, MCL1, KRAS ERN1 2891/4885ALDH1A1 3206/4885CYP2C9 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.